Vimarsana
Biggest News Aggregation in the World

Page 22 - Population Science News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Population Science. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Population Science Today - Breaking & Trending Today

Lung Cancer Death Decline Associated With Screening, Earlier Diagnosis, and Surgery - Vimarsana News

Lung Cancer Death Decline Associated With Screening, Earlier Diagnosis, and Surgery

New York, NY (PRWEB) December 17, 2021 -- A recent, substantial decline in lung cancer deaths is associated with earlier diagnosis of lung cancer than in the

Source: prweb.com
Madhya Pradesh: Significant drop in chronic malnutrition in Guna kids, says Fifth National Family Health Survey - Vimarsana News

Madhya Pradesh: Significant drop in chronic malnutrition in Guna kids, says Fifth National Family Health Survey

Data show that chronic malnutrition among children below five years of age significantly reduced to 4.3%, which was earlier 12.1% in 2015-16

Study shows difference in outcomes for women treated with checkpoint inhibitors for melanoma - Vimarsana News

Study shows difference in outcomes for women treated with checkpoint inhibitors for melanoma

A class of cancer immunotherapy called checkpoint inhibitors has revolutionized cancer treatment. It's a new way to attack the disease by unleashing the immune system.

India is fighting rising online harassment in the workplace - Vimarsana News

India is fighting rising online harassment in the workplace

MUMBAI, India – When the world went into

Source: unfpa.org
IBD patients produce a strong antibody response to COVID-19 vaccination, finds study - Vimarsana News

IBD patients produce a strong antibody response to COVID-19 vaccination, finds study

Researchers at Cedars-Sinai found that patients with inflammatory bowel disease (IBD)─whose treatment can weaken the immune system─produced a strong antibody response to COVID-19 vaccination.